Brandon Allgood | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Brandon Allgood CTO and Co-Founder Numerate

Brandon Allgood, PhD, is the CTO and cofounder at Numerate, Inc, an AI driven drug discovery company. Brandon leads research and development of Numerate’s AI platform. He also leads the data science group, is the primary technical lead on both internal and collaborative drug discovery programs and is responsible for the technology vision at Numerate. Brandon has previously served as Director of Computational Science at Numerate and as a Research Scientist at Pharmix. He received a B.S. in Physics from the University of Washington, Seattle, and a Ph.D. in Computational Physics from the University of California, Santa Cruz. Brandon has authored scientific publications in astrophysics, solid-state physics, and computational chemistry and biology and has 15 years of experience in AI, mathematical modeling, and large scale cloud and distributed computing. He advises a number of venture capital firms and start-up companies, is a cofounder of the Alliance for AI in Healthcare, a member of the Forbes Technology Council and a University of California, Santa Cruz Foundation Trustee.

Presenting: